SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Cashflow Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-239 Cr | ₹-360 Cr | ₹-429 Cr | ₹-69 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹-239 Cr |
| Mar2025 | ₹-360 Cr |
| Mar2024 | ₹-429 Cr |
| Mar2023 | ₹-69 Cr |
How is Cash Flow from Operating Activities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-239 Cr | Negative | |
| Mar2025 | ₹-360 Cr | Negative | |
| Mar2024 | ₹-429 Cr | Negative | |
| Mar2023 | ₹-69 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,014.6 Cr | -1.8% | -4.1% | 40.5% | Stock Analytics | |
| PRIME FOCUS | ₹22,432.6 Cr | 3.3% | -13.9% | 71.7% | Stock Analytics | |
| SAGILITY | ₹20,602.5 Cr | NA | -1.7% | -2.3% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,051.9 Cr | 4.9% | 4.7% | -39% | Stock Analytics | |
| INDEGENE | ₹14,144.5 Cr | 1.1% | -0.7% | 9.1% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹13,896.1 Cr | 1.3% | 2% | -4.5% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -1.8% |
-4.1% |
40.5% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses